Tetracycline Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Acne 22.9%
Asthma 12.5%
Complex Regional Pain Syndrome 6.3%
Ear Infection 6.3%
Staphylococcal Infection 6.3%
Diabetes Mellitus 4.2%
Dysuria 4.2%
General Body Pain 4.2%
Glaucoma 4.2%
Infection 4.2%
Pain 4.2%
Vomiting In Pregnancy 4.2%
Blood Pressure 2.1%
Chronic Obstructive Pulmonary Disease 2.1%
Erectile Dysfunction 2.1%
Gastrooesophageal Reflux Disease 2.1%
Headache 2.1%
Hypersensitivity 2.1%
Hypertension 2.1%
Hypothyroidism 2.1%
Drug Hypersensitivity 50.0%
Tooth Discolouration 22.7%
Rash 4.7%
Tooth Disorder 2.9%
Vomiting 2.9%
No Adverse Event 2.3%
Maternal Exposure Timing Unspecified 1.7%
Suicidal Ideation 1.7%
Urticaria 1.7%
Hypersensitivity 1.2%
Nausea 1.2%
Stevens-johnson Syndrome 1.2%
Tooth Injury 1.2%
Visual Impairment 1.2%
Abdominal Pain Upper 0.6%
Angioedema 0.6%
Back Disorder 0.6%
Congenital Anomaly 0.6%
Culture Positive 0.6%
Diarrhoea 0.6%
Secondary
Product Used For Unknown Indication 36.0%
Helicobacter Gastritis 16.0%
Bacterial Infection 12.0%
Eye Infection 8.0%
Acne 4.0%
Age-related Macular Degeneration 4.0%
Diuretic Therapy 4.0%
Hypertension 4.0%
Metastases To Pancreas 4.0%
Pharyngeal Cancer Stage Unspecified 4.0%
Prophylaxis 4.0%
Drug Hypersensitivity 70.9%
No Adverse Event 6.3%
Rash 6.3%
Anaphylactic Reaction 1.3%
Aplastic Anaemia 1.3%
Clostridium Difficile Colitis 1.3%
Corneal Erosion 1.3%
Drug Eruption 1.3%
Drug Intolerance 1.3%
Eczema 1.3%
Feeling Abnormal 1.3%
Haematochezia 1.3%
Hypersensitivity 1.3%
Refusal Of Treatment By Patient 1.3%
Thrombocytopenia 1.3%
Yellow Skin 1.3%
Concomitant
Non-small Cell Lung Cancer 35.0%
Chronic Myeloid Leukaemia 15.0%
Metastatic Gastric Cancer 15.0%
B-cell Lymphoma 10.0%
Hiv Infection 10.0%
Crohn's Disease 5.0%
Hypertension 5.0%
Pulmonary Arterial Hypertension 5.0%
Weight Increased 15.4%
Convulsion 7.7%
Death 7.7%
Dizziness 7.7%
Ear Disorder 7.7%
Fatigue 7.7%
Haematemesis 7.7%
Haemorrhage 7.7%
Pancytopenia 7.7%
Pneumonia 7.7%
White Blood Cell Count Decreased 7.7%
White Blood Cell Count Increased 7.7%
Interacting
Contraception 50.0%
Oropharyngeal Pain 50.0%
Unintended Pregnancy 100.0%